MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 75 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,315,403 | -26.0% | 163,404 | -0.2% | 0.00% | – |
| Q2 2023 | $1,778,543 | +395.6% | 163,770 | +214.9% | 0.00% | – |
| Q1 2023 | $358,890 | +371.7% | 52,013 | +172.1% | 0.00% | – |
| Q4 2022 | $76,085 | -41.5% | 19,117 | -1.9% | 0.00% | – |
| Q3 2022 | $130,000 | +32.7% | 19,482 | -3.8% | 0.00% | – |
| Q2 2022 | $98,000 | -91.3% | 20,262 | -83.1% | 0.00% | – |
| Q1 2022 | $1,124,000 | -21.5% | 120,205 | -0.3% | 0.00% | – |
| Q4 2021 | $1,432,000 | +5.8% | 120,536 | +1.4% | 0.00% | – |
| Q3 2021 | $1,353,000 | -26.5% | 118,897 | +15.9% | 0.00% | – |
| Q2 2021 | $1,841,000 | +24.6% | 102,627 | +7.5% | 0.00% | – |
| Q1 2021 | $1,478,000 | +37.2% | 95,455 | +8.1% | 0.00% | – |
| Q4 2020 | $1,077,000 | +28.5% | 88,297 | +35.4% | 0.00% | – |
| Q3 2020 | $838,000 | – | 65,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |